Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
FER overexpression
Cancer:
Triple Negative Breast Cancer
Drug:
docetaxel
(
Tubulin polymerization promoter
,
Microtubule stabilizer
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Cell Rep
Title:
FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer
Published date:
04/05/2022
Excerpt:
Strikingly, high-FER MM231 cells displayed a 9-fold higher sensitivity to docetaxel (Figure 2B; half maximal inhibitory concentration [IC50] = 0.63 versus 5.7 nM) and paclitaxel when compared with MM468 cells (Figure S1B; IC50 = 0.93 versus 4.67 nM).
DOI:
10.1016/j.celrep.2022.110584
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login